Regulation of B-cell activation and differentiation by the phosphatidylinositol 3-kinase and phospholipase Cγ pathways

Immunological Reviews

Volumn 176, Issue , 2000, Pages 30-46

  Marshall, A J ^a   Niiro, H ^a   Yun, T J ^a   Clark, E A ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE ANTIGEN; CALCIUM; CD19 ANTIGEN; DIACYLGLYCEROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INOSITOL 1,4,5 TRISPHOSPHATE; LINK PROTEIN; LIPID; LYMPHOCYTE ANTIGEN RECEPTOR; NUCLEAR FACTOR; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4 BISPHOSPHATE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PHOSPHOLIPASE C; PHOSPHOLIPID; PROTEIN KINASE C;

B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; CALCIUM MOBILIZATION; CELL FATE; CELL SELECTION; ENZYME ACTIVATION; ENZYME LOCALIZATION; ENZYME REGULATION; HUMORAL IMMUNITY; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION;

EID: 0033812082     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2000.00611.x     Document Type: Review

References (204)

1. Signal transduction pathways which regulate the fate of B lymphocytes
2. Genetic analysis of B cell antigen receptor signaling
3. Intermediary signaling effectors coupling the B-cell receptor to the nucleus
4. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death
5. Cellular mechanisms of immunological tolerance
6. Positive versus negative signaling by lymphocyte antigen receptors
7. Neutralizing antivral B cell responses
8. CD 19 regulates B lymphocyte responses to transmembrane signals
9. Association of tyrosine and serine kinases with the B cell surface antigen CD20. Induction via CD20 of tyrosine phosphorylation and activation of phospholipase C-γ 1 and PLC phospholipase C-γ 2
10. CD22 regulates thymus-independent responses and the lifespan of B cells
11. CD40 and its ligand
12. How B and T cells talk to each other
13. Parnes CD72-deficient mice reveal nonredundant roles of CD72 in B cell development and activation
14. Expansion or elimination of B cells in viva dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor
15. Autoimmunity. The Fas track
16. Soluble and membrane-bound forms of signaling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytes
17. CDw 150 associates with src-homology 2-containing inositol phosphatase and modulates CD95-mediated apoptosis
18. Inhibitory signaling by B cell FcγRIIb
19. Antigen receptor-initiated signals for B cell development and selection
20. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia
21. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice
22. An essential role for BLNK in human B cell development
23. CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM
24. Defective CD95/APO- 1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome type Ia
25. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity
26. Closely related BCR/ABL oncogenes are associated with the distinctive clinical biologies of Philadelphia chromosome positive chronic myelogenous and acute lymphocytic leukemia
27. Clonal deleterious mutations in the IκB α gene in the malignant cells in Hodgkin's lymphoma
28. Antigen receptor signaling: Integration of protein tyrosine kinase functions
29. The complexity of signaling pathways activated by the BCR
30. Tyrosine phosphorylation of phospholipase C-γ 2 upon cross-linking of membrane Ig on murine B lymphocytes
31. Tyrosine phosphorylation of phospholipase C induced by membrane immunoglobulin in B lymphocytes
32. Significance of PIP2 hydrolysis and regulation of phospholipase C isozymes
33. Phosphatidylinositol hydrolysis: A multifunctional transducing mechanism
34. Signalling through the lipid products of phosphoinositide-3-OH kinase
35. Signalling through phosphoinositide 3-kinases: The lipids take centre stage
36. FYVE-finger proteins-effectors of an inositol lipid
37. Both phosphatidylinositol 3-kinase and phosphatidylinositol 4-kinase products are increased by antigen receptor signaling in B cells
38. Novel polyphosphoinositides in cell growth and activation
39. The role of phosphoinositide 3-kinase lipid products in cell function
40. A comparative analysis of the phosphoinositide binding specificity of pleckstrin homology domains
41. Pleckstrin homology domains
42. Specificity and promiscuity in phosphoinositide binding by pleckstrin homology domains
43. Identification and analysis of PH domain-containing targets of phosphatidylinositol 3-kinase using a novel in vivo assay in yeast
44. Distinct specificity in the recognition of phosphoinositides by the pleckstrin homology domains of dynamin and the Bruton's tyrosine kinase
45. High affinity binding of inositol phosphates and phosphoinositides to the pleckstrin homology domain of RAC/protein kinase B and their influence on kinase activity
46. Nerve growth factor- and epidermal growth factor-stimulated translocation of the ADP-ribosylation factor-exchange factor GRP1 to the plasma membrane of PC 12 cells requires activation of phosphotidylinositol 3-kinase and the GRP1 pleckstrin homology domain
47. The PH domain and polybasic domain of cytohesin-1 cooperate specifically in plasma membrane association and cellular function
48. Phosphatidylinositol 3-kinase-dependent membrane association of the Bruton's tyrosine kinase pleckstrin homology domain visualized in single living cells
49. The dynamics of protein kinase B regulation during B cell antigen receptor engagement
50. CD 19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase
51. 2+ mobilization
52. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein kinase activation
53. The CR2/CD19 complex on human B cells contains the src-family kinase Lyn
54. Activation of phosphatidylinositol-3' kinase by Src-family kinase SH3 binding to the p85 subunit
55. Syk and Bruton's tyrosine kinase are required for B cell antigen receptor-mediated activation of the kinase Akt
56. The tyrosine kinases Syk and Lyn exert opposing effects on the activation of protein kinase Akt/PKB in B lymphocytes
57. Phosphoinositide 3-kinase is activated by phosphopeptides that bind to the SH2 domains of the 85-kDa subunit
58. SYK is upstream of phosphoinositide 3-kinase in B cell receptor signaling
59. Characterization of Cbl tyrosine phosphorylation and a Cbl-Syk complex in RBL-2H3 cells
60. Coordinated regulation of the tyrosine phosphorylation of Cbl by Fyn and Syk tyrosine kinases
61. p120cbl is a major substrate of tyrosine phosphorylation upon B cell antigen receptor stimulation and interacts in viva with Fyn and Syk tyrosine kinases, Grb2 and Shc adaptors, and the p85 subunit of phosphatidylinositol 3-kinase
62. Association of activated phosphatidylinositol 3-kinase with p120cbl in antigen receptor-ligated B cells
63. Cbl suppresses B cell receptor-mediated phospholipase C (PLC)-γ2 activation by regulating B cell linker protein-PLC-γ2 binding
64. A Grb2-associated docking protein in EGF- and insulin-receptor signalling
65. A novel positive feedback loop mediated by the docking protein Gab 1 and phosphatidylinositol 3-kinase in epidermal growth factor receptor signaling
66. Gab-family adapter proteins act downstream of cytokine and growth factor receptors and T- and B-cell antigen receptors
67. The Gab1 protein is a docking site for multiple proteins involved in signaling by the B cell antigen receptor
68. Membrane Ig cross-linking regulates phosphatidylinositol 3-kinase in B lymphocytes
69. Bruton's tyrosine kinase controls a sustained calcium signal essential for B lineage development and function
70. 2+ mobilization through distinct pathways
71. A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-γ 2
72. Requirement of phospholipase C-γ 2 in surface immunoglobulin M-induced B cell apoptosis
73. Identification of two tyrosine phosphoproteins, pp70 and pp68, which interact with phospholipase Cγ, Grb2, and Vav after B cell antigen receptor stimulation
74. BLNK: A central linker protein in B cell activation
75. BASH, a novel signaling molecule preferentially expressed in B cells of the bursa of Fabricius
76. SLP-65: A new signaling component in B lymphocytes which requires expression of the antigen receptor for phosphorylation
77. Association of phospholipase C-γ2 src homology 2 domains with BLNK is critical for B cell antigen receptor signaling
78. Functional independence and interdependence of the Src homology domains of phospholipase C-γ1 in B-cell receptor signal transduction
79. BLNK required for coupling Syk to PLC γ 2 and Rac 1 -JNK in B cells
80. Nonreceptor protein tyrosine kinase involvement in signal transduction and immunodeficiency disease
81. Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3)/Tec kinase- dependent calcium signaling pathway: A target for SHIP-mediated inhibitory signals
82. 2+ following B-cell receptor activation
83. Activation of BTK by a phosphorylation mechanism initiated by SRC family kinases
84. Interaction of SLP adaptors with the SH2 domain of Tec family kinases
85. Identification of the SH2 domain binding protein of Bruton's tyrosine kinase as BLNK - Functional significance of Btk-SH2 domain in B-cell antigen receptor-coupled calcium signaling
86. Phosphorylation of CD 19 Y484 and Y5 1 5, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase
87. Activation of phopholipase Cγ by PI 3-kinase-induced PH domain-mediated membrane targeting
88. Activation of phospholipase C-γ by phosphatidylinositol 3,4,5-trisphosphate
89. GrpL, a Grb2-related adaptor protein, interacts with SLP-76 to regulate nuclear factor of activated T cell activation
90. The hematopoietic-specific adaptor protein gads functions in T-cell signaling via interactions with the SLP-76 and LAT adaptors
91. Integration of T cell receptor-dependent signaling pathways by adapter proteins
92. The product of the proto-oncogene c-cbl: A negative regulator of the Syk tyrosine kinase
93. Point mutation of a tyrosine in the linker region of Syk results in a gain of function
94. Inhibition of signaling through the B cell antigen receptor by the protooncogene product, c-Cbl, requires Syk tyrosine 317 and the c-Cbl phosphotyrosine-binding domain
95. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase
96. The Cbl proto-oncogene product negatively regulates the Src-family tyrosine kinase Fyn by enhancing its degradation
97. Cloning and characterization of cbl-b: A SH3 binding protein with homology to the c-cbl proto-oncogene
98. Negative regulation of lymphocyte activation and autoimmunity by the molecule adaptor Cbl-b
99. The B cell antigen receptor activates the Akt (protein kinase B)/glycogen synthase kinase-3 signaling pathway via phosphatidylinositol 3-kinase
100. The inositol phosphatase SHIP inhibits Akt/PKB activation in B cells
101. A novel B lymphocyte-associated adaptor protein, Bam32, regulates antigen receptor signaling downstream of phosphatidylinositol 3-kinase
102. Mechanisms and consequences of activation of protein kinase B/Akt
103. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase
104. Role of translocation in the activation and function of protein kinase B
105. Mechanism of activation of protein kinase B by insulin and IGF-1
106. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα
107. Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B
108. Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B
109. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt
110. Regulation of cell death protease caspase-9 by phosphorylation
111. NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase
112. NF-κB is a target of AKT in anti-apoptotic PDGF signalling
113. Induction of NF-κB by the Akt/PKB kinase
114. B lymphocytes differentially use the Rel and nuclear factor κB1 (NF-κB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells
115. Inhibition of NF-κB/Rel induces apoptosis of murine B cells
116. NF-κB and Rel proteins: Evolutionarily conserved mediators of immune responses
117. Essential role for protein kinase B (PKB) in insulin-induced glycogen synthase kinase 3 inactivation. Characterization of dominant-negative mutant of PKB
118. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3
119. Mutation of the pleckstrin homology domain of Bruton's tyrosine kinase in immunodeficiency impaired inositol 1,3,4,5-tetrakisphosphate binding capacity
120. The pleckstrin homology domain of Bruton tyrosine kinase interacts with protein kinase C
121. Bruton's tyrosine kinase (Btk) associates with protein kinase Cμ
122. DAPP1: A dual adaptor for phosphotyrosine and 3-phosphoinositides
123. The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase
124. Activation-induced association of a 145-kDa tyrosine-phosphorylated protein with Shc and Syk in B lymphocytes and macrophages
125. The src homology domain 2-containing inositol phosphatase SHIP forms a ternary complex with Shc and Grb2 in antigen receptor-stimulated B lymphocytes
126. Tyrosine phosphorylation of Shc in response to B cell antigen receptor engagement depends on the SHIP inositol phosphatase
127. Negative signaling in B cells: SHIP Grbs Shc
128. Role of the inositol phosphatase SHiP in negative regulation of the immune system by the receptor FcγRIIB
129. Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling
130. Redistribution of Bruton's tyrosine kinase by activation of phosphatidylinositol 3-kinase and Rhofamily GTPases
131. SHIP modulates immune receptor responses by regulating membrane association of Btk
132. SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival
133. A dual role for Src homology 2 domain-containing inositol-5-phosphatase (SHIP) in immunity Aberrant development and enhanced function of B lymphocytes in SHIP(-/-) mice
134. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway
135. The multiple roles of PTEN in tumor suppression
136. The minor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate
137. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
138. The store-operated calcium current I(CRAC): Nonlinear activation by InsP3 and dissociation from calcium release
139. The signal for capacitative calcium entry
140. Signal transduction between the plasma membrane and the nucleus of T lymphocytes
141. 2+ response amplitude and duration
142. 2+ signals and immunosupression
143. Protein kinase Cμ (PKCμ) associates with the B cell antigen receptor complex and regulates lymphocyte signaling
144. Protein kinase C-δ is a target of B-cell antigen receptor signaling
145. B cell receptor cross-linking prevents Fas-induced cell death by inactivating the IL-1 β-converting enzyme protease and regulating Bcl-2/Bd-x expression
146. Selective activation of p42 mitogen-activated protein (MAP) kinase in murine B lymphoma cell lines by membrane immunoglobulin cross-linking. Evidence for protein kinase C-independent and -dependent mechanisms of activation
147. Cyclosporin-A sensitive induction of NF-AT in murine B cells
148. Function and activation of NF-κB in the immune system
149. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement
150. RAG-1-deficient mice have no mature B and T lymphocytes
151. B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene
152. Regulation of an early developmental checkpoint in the B cell pathway by Ig β
153. A critical role of λ5 protein in B cell development
154. Influence of immunoglobulin heavy- and light-chain expression on B-cell differentiation
155. Functional immunoglobulin transgenes guide ordered B-cell differentiation in Rag-1-deficient mice
156. The role of Ig β in precursor B cell transition and allelic exclusion
157. The cytoplasmic domains of immunoglobulin (Ig) α and Ig β can independently induce the precursor B cell transition and allelic exclusion
158. The Ig α/Igβ heterodimer on μ-negative proB cells is competent for transducing signals to induce early B cell differentiation
159. Stimulation of B-cell progenitors by cloned murine interleukin-7
160. Recombinant interleukin-7 supports the growth of normal B lymphocyte precursors
161. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine
162. Modulation of the IL-7 dose-response threshold during pro-B cell differentiation is dependent on pre-B cell receptor expression
163. Inhibition of interleukin 7 receptor signaling by antigen receptor assembly
164. Requirement for B cell linker protein (BLNK) in B cell development
165. Abnormal development and function of B lymphocytes in mice deficient for the signaling adaptor protein SLP-65
166. Xid-like immunodeficiency in mice with disruption of the p85α subunit of phosphoinositide 3-kinase
167. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85α
168. Defective B cell development and function in Btk-deficient mice
169. Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk
170. Syk tyrosine kinase required for mouse viability and B-cell development
171. The turnover of B-cell populations
172. The bulk of the peripheral B-cell pool in mice is stable and not rapidly renewed from the bone marrow
173. Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk
174. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals
175. Regulation of B-lymphocyte negative and positive selection by tyrosine phosphatase CD45
176. Most peripheral B cells in mice are ligand selected
177. Positive selection of natural autoreactive B cells
178. Transitional B cells are the target of negative selection in the B cell compartment
179. Altered immunoglobulin expression and functional silencing of selfreactive B lymphocytes in transgenic mice
180. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens
181. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes
182. Syk tyrosine kinase is required for the positive selection of immature B cells into the recirculating B cell pool
183. Immunoglobulin-mediated signal transduction in B cells from CD45-deficient mice
184. Normal B lymphocyte development, but impaired T cell maturation in CD45-exon6 protein tyrosine phosphatase-deficient mice
185. Aberrant B cell development and immune response in mice with a compromised BCR complex
186. Ig-αcytoplasmic truncation renders immature B cells more sensitive to antigen contact
187. A negative regulatory role for Ig-α during B cell development
188. Polygenic autoimmune traits: Lyn, CD22 and SHP-1 are limiting elements of abiochemical pathway regulating BCR signaling and selection
189. Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation
190. Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection
191. Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span
192. The inositol polyphosphate 5-phosphatase SHIP is a crucial negative regulator of B cell antigen receptor signaling
193. PTEN is essential for embryonic development and tumour suppression
194. Impaired Fas response and autoimmunity in Pten(+/-) mice
195. Rearrangement and selection of VH11 in the Ly-1 B cell lineage
196. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD 19-deficient mice
197. Abnormal B lymphocytes development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule
198. Immunodeficiency in protein kinase cβ-deficient mice
199. Inducible gene targeting in mice
200. PTEN gene alterations in lymphoid neoplasms
201. The molecular and cellular origins of Hodgkin's disease
202. Overexpression of I κ B α without inhibition of NF-κB activity and mutations in the I κ B α gene in Reed-Sternberg cells
203. Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma
204. Functionally different subpopulations of B cells are defined by CD22 expression and two color flow cytometry